Cart summary

You have no items in your shopping cart.

    Linifanib (ABT-869)

    Catalog Number: orb154718

    DispatchUsually dispatched within 5-10 working days.
    $ 2,156.00
    Catalog Numberorb154718
    CategorySmall Molecules
    DescriptionABT-869 is an ATP-competitive, multi-targeted RTK inhibitor that is completely effective against all members of the vascular endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) receptor families.
    CAS Number[796967-16-3]
    MW375.405
    SMILESO=C(NC1=CC=C(C2=C3C(N)=NNC3=CC=C2)C=C1)NC4=C(C=CC(C)=C4)F
    FormulaC21H18FN5O
    NoteFor research use only
    Expiration Date12 months from date of receipt.
    Linifanib (ABT-869)

    Chemical structure of Linifanib (ABT-869)

    • ABT-869 [orb1804885]

      > 98%

      796967-16-3

      375.4

      C21H18FN5O

      25 mg, 5 mg
    • Linifanib (ABT-869) [orb1101731]

      > 98%

      [796967-16-3]

      375.41

      C21H18FN5O

      20 mg
    • Linifanib (ABT-869) [orb1905678]

      796967-16-3

      50 mg
    • Linifanib (ABT-869) [orb1905679]

      796967-16-3

      5 mg
    • Linifanib (ABT-869) [orb1905681]

      796967-16-3

      100 mg
    Submit a review

    Filter by Rating

      • Star
      • Star
      • Star
      • Star
      • Star
      • 5 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 4 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 3 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 2 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 1 stars